SJ Proctor
- Hematology top 2%
- Hematopoietic Stem Cell Transplantation 14
- Chronic Myeloid Leukemia Treatments 6
- Multiple Myeloma Research and Treatments 4
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 8
-
- Lymphoma Diagnosis and Treatment 14
- Oncology top 10%
-
- Acute Lymphoblastic Leukemia research 11
-
- Lung Cancer Treatments and Mutations 5
-
- Immune Cell Function and Interaction 4
SJ Proctor
57 papers receiving 985 citations
Peers
Comparison fields: 5 of 97
- Hematology 478
- Genetics 171
- Pathology and Forensic Medicine 233
- Oncology 256
- Public Health, Environmental and Occupational Health 247
Countries citing papers authored by SJ Proctor
This map shows the geographic impact of SJ Proctor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by SJ Proctor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites SJ Proctor more than expected).
Fields of papers citing papers by SJ Proctor
This network shows the impact of papers produced by SJ Proctor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by SJ Proctor. The network helps show where SJ Proctor may publish in the future.
Co-authorship network
The 25 scholars most cited alongside SJ Proctor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 34 | |
| 2 | 2007 | 2 | |
| 3 | 2006 | 8 | |
| 4 | 2006 | 5 | |
| 5 | 2001 | 15 | |
| 6 | 2000 | 14 | |
| 7 | 1999 | 3 | |
| 8 | 1999 | 5 | |
| 9 | 1999 | 18 | |
| 10 | 1998 | 6 | |
| 11 | 1997 | 53 | |
| 12 | Cytokine treatment of human bone marrow activates anti-leukaemia effector cells: monitoring of purging by polymerase chain reaction and DNA analysis. | 1995 | 5 |
| 13 | 1994 | 13 | |
| 14 | 1993 | 23 | |
| 15 | Classical staging of Hodgkin's disease is inappropriate for selecting patients for clinical trials of intensive therapy: the case for the objective use of prognostic factor information in addition to classical staging. | 1993 | 7 |
| 16 | 1988 | 1 | |
| 17 | 1987 | 14 | |
| 18 | 1984 | 9 | |
| 19 | Autoantibody synthesis by thyroid lymphocytes | 1982 | 4 |
| 20 | 1981 | 1 |
About SJ Proctor
SJ Proctor is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Oncology and Public Health, Environmental and Occupational Health, having authored 57 papers that have together received 1.0k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (14 papers), Lymphoma Diagnosis and Treatment (14 papers), Acute Lymphoblastic Leukemia research (11 papers), Chronic Lymphocytic Leukemia Research (8 papers), Chronic Myeloid Leukemia Treatments (6 papers), Lung Cancer Treatments and Mutations (5 papers), Multiple Myeloma Research and Treatments (4 papers) and Immune Cell Function and Interaction (4 papers). The work is most often cited by research in Hematology (478 citations), Genetics (171 citations), Pathology and Forensic Medicine (233 citations), Oncology (256 citations) and Public Health, Environmental and Occupational Health (247 citations). SJ Proctor has collaborated with scholars based in United Kingdom, Czechia and Iraq. Frequent co-authors include P. J. Hamilton, P J Carey, P Taylor, Lisbet Sviland, Jennifer Wilkinson, David W. Rowe, G Jackson, Peter G. Middleton, Michal Sieniawski and Patrick Hamilton. Their work appears in journals such as Blood, British Journal of Cancer, British Journal of Haematology, Leukemia and Journal of Clinical Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.